Abstract
127P A prospective phase II clinical trial exploring neoadjuvant immunotherapy combined with chemotherapy in resectable thoracic esophageal squamous cell cancer (TESCC) with multi-station lymph node metastases (NICE study): Preliminary results
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have